$44.45
2.54%
NYSE, Jan 02, 10:02 pm CET

CryoLife Stock price

$44.46
-0.91 2.01% 1M
+13.61 44.12% 6M
-1.15 2.52% YTD
+16.38 58.33% 1Y
+32.34 266.83% 3Y
+21.02 89.68% 5Y
+34.15 331.23% 10Y
+41.12 1,231.14% 20Y
NYSE, Closing price Fri, Jan 02 2026
-1.15 2.52%

Key metrics

Basic
Market capitalization
$2.1b
Enterprise Value
$2.3b
Net debt
$145.0m
Cash
$73.4m
Shares outstanding
47.4m
Valuation (TTM | estimate)
P/E
negative | 231.5
P/S
5.0 | 4.7
EV/Sales
5.3 | 5.0
EV/FCF
128.6
P/B
4.8
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$422.7m | $450.6m
EBITDA
$36.9m | $91.3m
EBIT
$22.2m | $32.3m
Net Income
$-9.1m | $9.1m
Free Cash Flow
$17.5m
Growth (TTM | estimate)
Revenue
9.8% | 16.0%
EBITDA
-19.6% | 57.5%
EBIT
-25.6% | -22.0%
Net Income
-972.9% | 168.2%
Free Cash Flow
55.6%
Margin (TTM | estimate)
Gross
64.5%
EBITDA
8.7% | 20.3%
EBIT
5.3%
Net
-2.2% | 2.0%
Free Cash Flow
4.1%
Financial Health
Equity Ratio
35.0%
Return on Equity
-4.8%
ROCE
2.9%
ROIC
3.3%
Debt/Equity
0.5
More
EPS
$-0.2
FCF per Share
$0.4
Short interest
3.1%
Employees
2k
Rev per Employee
$240.0k
Show more

Is CryoLife a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

CryoLife Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

11x Buy
85%
2x Hold
15%

Analyst Opinions

13 Analysts have issued a CryoLife forecast:

Buy
85%
Hold
15%

Financial data from CryoLife

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
423 423
10% 10%
100%
- Direct Costs 150 150
10% 10%
36%
273 273
10% 10%
64%
- Selling and Administrative Expenses 204 204
17% 17%
48%
- Research and Development Expense 29 29
2% 2%
7%
37 37
20% 20%
9%
- Depreciation and Amortization 15 15
8% 8%
3%
EBIT (Operating Income) EBIT 22 22
26% 26%
5%
Net Profit -9.12 -9.12
973% 973%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about CryoLife directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoLife Stock News

Positive
Seeking Alpha
5 days ago
Artivion continues to outperform the med-tech sector, driven by strong execution in stent grafts and On-X valve businesses. Recent clinical updates for the AMDS prosthesis reinforce its safety and efficacy, supporting further adoption and de-risking full commercialization. I expect double-digit long-term revenue growth, expanding EBITDA margins, and a fair value in the high-$50s, justifying a b...
Neutral
Seeking Alpha
about 2 months ago
Class A shares of the Alger Weatherbie Specialized Growth Fund underperformed the Russell 2500 Growth Index during the third quarter of 2025. Semtech Corporation (SMTC), Impinj Inc. (PI), and Artivion, Inc. (AORT) were among the top contributors to performance. SPS Commerce, Inc. (SPSC), Palomar Holdings, Inc. (PLMR), and Vertex, Inc. (VRTX) were among the top detractors from performance.
Neutral
Seeking Alpha
about 2 months ago
Artivion, Inc. ( AORT ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Pat MacKin Lance Berry - EVP, COO, CFO & Treasurer Conference Call Participants Lynn Lewis - Gilmartin Group LLC John McAulay - Stifel, Nicolaus & Company, Incorporated, Research Division Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Suraj Kalia - Oppenheimer & Co. Inc., Resear...
More CryoLife News

Company Profile

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Head office United States
CEO James Mackin
Employees 1,600
Founded 1984
Website artivion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today